Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Chengdu Kanghong Pharmaceutical Group

Market Cap: CN¥33.6b

Research, develops, manufactures, and distributes medicine for ophthalmic, neuropsychiatric and other applications in China.

Vcanbio Cell & Gene Engineering

Market Cap: CN¥10.9b

Engages in the preparation and storage of cell detection tests in the People’s Republic of China.

HLB TherapeuticsLtd

Market Cap: ₩262.8b

A biotech company, develops pharmaceutical products in South Korea and internationally.

HOB Biotech GroupLtd

Market Cap: CN¥9.4b

Operates as a in vitro diagnostic company in China and internationally.

Acutaas Chemicals

Market Cap: ₹111.2b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Stella Pharma

Market Cap: JP¥12.4b

Engages in the research, development, manufacturing, and distribution of pharmaceuticals.

Abbott Laboratories (Pakistan)

Market Cap: PK₨124.5b

Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.

Medicalsystem Biotechnology

Market Cap: CN¥3.9b

Engages in the research, development, production, and sales of in vitro diagnostic products in China.

Handa Pharmaceuticals

Market Cap: NT$18.5b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.

Jenburkt Pharmaceuticals

Market Cap: ₹4.8b

Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.

CellBion

Market Cap: ₩229.5b

Engages in the research and development of radiopharmaceutical products.

Guizhou Xinbang Pharmaceutical

Market Cap: CN¥6.5b

Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.

Emyria

Market Cap: AU$39.8m

Engages in delivering and developing of treatments for mental health and select neurological conditions in Australia.

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd

Market Cap: HK$8.1b

Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.

Jiangsu Kanion PharmaceuticalLtd

Market Cap: CN¥8.5b

Researches and develops, produces, and sells Chinese medicines.

Inner Mongolia Furui Medical Science

Market Cap: CN¥20.0b

Inner Mongolia Furui Medical Science Co., Ltd.

Simcere Pharmaceutical Group

Market Cap: HK$32.4b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥48.3b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

BioNote

Market Cap: ₩591.9b

Manufactures and sells in-vitro diagnostic animal medicines in South Korea.

Grand Pharmaceutical Group

Market Cap: HK$29.3b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.8b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

Jacobson Pharma

Market Cap: HK$2.9b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

Nang Kuang Pharmaceutical

Market Cap: NT$3.8b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

Gan & Lee Pharmaceuticals

Market Cap: CN¥46.5b

A biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥16.1b

Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.

Tdspharm

Market Cap: ₩54.8b

Researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally.

Beximco Pharmaceuticals

Market Cap: ৳54.4b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

HLB Pep

Market Cap: ₩64.5b

A bio-venture company, engages in the manufacture and sale of peptide biomaterials and drug raw materials in South Korea and internationally.

Immuron

Market Cap: AU$20.4m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Orum Therapeutics

Market Cap: ₩670.0b

A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases.

Samsrita Labs

Market Cap: ₹433.2m

Operates as a biopharmaceutical company in India.

TaiMed Biologics

Market Cap: NT$20.8b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

MiMedx Group

Market Cap: US$1.0b

Develops and distributes placental tissue allografts for various sectors of healthcare.

AlzeCure Pharma

Market Cap: SEK 293.0m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

Avadel Pharmaceuticals

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States.

Annexon

Market Cap: US$370.3m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.